Jump to content
  • entries
    167
  • comments
    160
  • views
    263,761

U.s. Government Licenses Patent For Medical Marijuana


Michael Komorn

673 views

 

 

U.S. Government Licenses Patent for Medical Marijuana

It has been well documented that the Federal Government is aware of the medical benefits of cannabis. Yet marijuana remains a controlled 1 substance. This fact makes the following very difficult to reconcile.

 

Thursday, December 15, 2011 U.S. Department of Health and Human Services is About to Award

Exclusive Rights to Apply Marijuana as a Medical Therapeutic

Deadline for Comment: Monday, Dec. 19

LOS ANGELES, CA – Dec. 15, 2011--The Union of Medical Marijuana Patients has just discovered that the U.S. Department of Health and Human Services is about to award an exclusive license to KannaLife Sciences, Inc. of New York to develop medical therapeutics based on the chemistry of cannabis. According to the notice in the Federal Register, public comments will be accepted through Monday, December 19.

"We find it hypocritical and incredible that on the one hand, the U.S. Department of Justice is persecuting medical cannabis patient associations, asserting that the federal government regards marijuana as having absolutely no medical value, despite overwhelming clinical evidence," said Union director James Shaw. "On the other hand, the Department of Health and Human Services is planning to grant patent rights with possible worldwide application to develop medicines based on cannabis."

While the Union applauds the U.S. government's efforts into researching the medical value of cannabis, Shaw said, "they should have affirmatively rescheduled cannabis when they discovered it had medical efficacy and, of course, it makes no sense for the government to provide U.S. Patent 6,630,507, which the government owns, to a single company with exclusive rights." He urged medical cannabis patient associations and patients using marijuana for medical reasons to protest this giveaway to one pharmaceutical firm.

Comments need to be submitted in writing by next Monday to Betty B. Tong, Ph.D., Senior Licensing and Patenting Manager, Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville MD 20852-3804, fax (301) 402-0220, or tongb@mail.nih.gov.

More information on this issue can be found at www.Unionmmp.org.

Scott SmithThe Union of Medical Marijuana PatientsLos Angeles, CA310-254-4051

 

 

0 Comments


Recommended Comments

There are no comments to display.

Guest
Add a comment...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...


×
×
  • Create New...